Blue Mar Capital Management, LLC Catalent, Inc. Transaction History

Blue Mar Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $2.9 Million - $3.18 Million	-74,816 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $155,157 - $186,621	-3,938 Reduced 5.0%	74,816 $3.07 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $2.19 Million - $2.53 Million	-58,746 Reduced 42.72%	78,754 $3.24 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $4.64 Million - $5.73 Million	137,500	137,500 $5.49 Million

490

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Blue Mar Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Mar Capital Management, LLC with notifications on news.